SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-16-083157
Filing Date
2016-02-18
Accepted
2016-02-18 09:50:31
Documents
15
Period of Report
2016-02-18

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v432180_6k.htm 6-K 53688
2 EXHIBIT 99.1 v432180_ex99-1.htm EX-99.1 41281
3 EXHIBIT 99.2 v432180_ex99-2.htm EX-99.2 5591
4 GRAPHIC ex99x1_001.jpg GRAPHIC 3271
5 GRAPHIC ex99x2_001.jpg GRAPHIC 254093
6 GRAPHIC ex99x2_002.jpg GRAPHIC 324943
7 GRAPHIC ex99x2_003.jpg GRAPHIC 201384
8 GRAPHIC ex99x2_004.jpg GRAPHIC 274436
9 GRAPHIC ex99x2_005.jpg GRAPHIC 557040
10 GRAPHIC ex99x2_006.jpg GRAPHIC 555757
11 GRAPHIC ex99x2_007.jpg GRAPHIC 139729
12 GRAPHIC ex99x2_008.jpg GRAPHIC 236781
13 GRAPHIC ex99x2_009.jpg GRAPHIC 136316
14 GRAPHIC ex99x2_010.jpg GRAPHIC 452686
15 GRAPHIC ex99x2_011.jpg GRAPHIC 529252
  Complete submission text file 0001144204-16-083157.txt   5142210
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-36000 | Film No.: 161436210
SIC: 2834 Pharmaceutical Preparations